Abiopharma

New Form 424B3 - MSP Recovery, Inc. Filed: 2025-08-26 AccNo: 0001802450-25-000046 Size: 1 MB

New Form 424B3 - MSP Recovery, Inc. Filed: 2025-08-26 AccNo: 0001802450-25-000044 Size: 1 MB

New Form 424B3 - MSP Recovery, Inc. Filed: 2025-08-26 AccNo: 0001802450-25-000045 Size: 1 MB

New Form 424B3 - MSP Recovery, Inc. Filed: 2025-08-26 AccNo: 0001802450-25-000043 Size: 1 MB

New Form 8-K/A - Tharimmune, Inc. Filed: 2025-08-26 AccNo: 0001641172-25-025585 Size: 770 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form PREM14A - Evofem Biosciences, Inc. Filed: 2025-08-26 AccNo: 0001641172-25-025582 Size: 7 MB

Director Diaz Allene M. 🔴 sold 1.4K shares of IONIS PHARMACEUTICALS INC (IONS) at $42.53 Transaction Date: Aug 22, 2025 | Filing ID: 000180

New Form PRE 14A - ETHZilla Corp Filed: 2025-08-26 AccNo: 0001213900-25-080796 Size: 3 MB

New Form S-3/A - MEI Pharma, Inc. Filed: 2025-08-26 AccNo: 0001140361-25-032760 Size: 642 KB

INVESTOR ALERT: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025

ELITE PHARMACEUTICALS INC /NV/ 🟡 adjusted position in 500.0K shares (1 derivative) of ELITE PHARMACEUTICALS INC /NV/ (ELTP) at $0.52 Transaction Date: Aug 22, 2025 | Filing ID: 012347

New Form 8-K - MSP Recovery, Inc. Filed: 2025-08-26 AccNo: 0001802450-25-000042 Size: 242 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Trinseo PLC Filed: 2025-08-26 AccNo: 0001558370-25-011764 Size: 459 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Director Aggarwal Gaurav 🟡 adjusted position in 0 shares (1 derivative) of Unicycive Therapeutics, Inc. (UNCY) at $4.90 ($3.2M) Transaction Date: Aug 25, 2025 | Filing ID: 080808

New Form ARS - Sonnet BioTherapeutics Holdings, Inc. Filed: 2025-08-26 AccNo: 0001641172-25-025562 Size: 4 MB